ONESOURCE SPECIALTY

ONESOURCE SPECIALTY Q4 HIGHLIGHTS Q4'25 revenue at $ 50.4m / 4,260m registered a 22% growth YoY with contribution from all businesses EBITDA: Quarterly EBITDA of $ 21.6m/1,825m, up 79% YoY driven by execution of high value MSAs EBITDA Margin: Margin improved by 1362 bps YoY to 43% driven by increased contribution from DDC and Operating Cost (Opex) leverage CEO Says Revenue rose 30% on strong growth and customer gains; EBITDA surged on better product mix, biologics, and efficiencies. Acquired entities’ integration driving cross-selling and cost synergies.